LegoChem Biosciences

141080.KQ

62.63 USD

-0.28

-0.45%

Overview

Last close

62.63 usd

Market cap

2.25B usd

52 week high

73.21 usd

52 week low

24.64 usd

Target price

73.66 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

39.2374

Price/Book Value

4.7849

Enterprise Value

1.83B usd

EV/Revenue

32.0937

EV/EBITDA

-31.9336

Key financials

Revenue TTM

56.99M usd

Gross Profit TTM

13.35M usd

EBITDA TTM

-36.28M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

739.33B usd

Net debt

N/A usd

About

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was formerly known as LegoChem Biosciences, Inc. and changed its name to LigaChem Biosciences Inc. in April 2024. LigaChem Biosciences Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.